Cardiology is an area of great recent triumphs in pharmacological and surgical treatment, yet cardiovascular disease remains the leading cause of death and disability in the industrialized world. Coronary disease, heart failure, stroke and sudden arrhythmic cardiac death challenge both medical practitioners and scientists. With the dawning of the new `molecular' era, there is an awakened hope that a more fundamental understanding of biologic processes may eventually lead to new progress in the prevention and treatment of these persistent and seemingly intransigent problems.
Pediatric cardiology section enlightens us on cardiovascular changes in fetuses /
infants as well as some pediatric cardiovascular surgical procedures needing skill
under recent developments. Pediatric hemato-oncology section explains novel
developments of well-known diseases such as neuroblastoma and thalassemias. For
instance; whole genome searches and molecular basis for diagnosis of neuroblastoma
are discussed. However, this section also includes some common complications of
oncology e.g. fertility and fatigue seen in these patients.
Therapeutic immunosuppression has very broad applications in clinical medicine,
ranging from prevention and treatment of organ and bone marrow transplant
rejection, management of various autoimmune disorders (e.g., rheumatoid arthritis),
skin diseases, allergies and asthma. Whereas traditionally only a small repertoire of
immunosuppressive agents was available for clinical use, recent discoveries have
significantly increased the number of approved agents, resulting in numerous trials to
further evaluate their potential.